Karin Collett

2.5k total citations · 1 hit paper
31 papers, 1.9k citations indexed

About

Karin Collett is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Karin Collett has authored 31 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Karin Collett's work include Breast Cancer Treatment Studies (12 papers), Pregnancy and preeclampsia studies (7 papers) and Cancer Cells and Metastasis (5 papers). Karin Collett is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Pregnancy and preeclampsia studies (7 papers) and Cancer Cells and Metastasis (5 papers). Karin Collett collaborates with scholars based in Norway, United States and Canada. Karin Collett's co-authors include Lars A. Akslen, Ingunn M. Stefansson, Ole J. Halvorsen, Svein A. Haukaas, Oddbjørn Straume, Arie P. Otte, Helga B. Salvesen, Ingeborg Bachmann, Jarle B. Arnes and Johan Eide and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Karin Collett

27 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast

2005 694 citations Ingeborg Bachmann, Ole J. Halvorsen et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Karin Collett

Since Specialization

Citations

This map shows the geographic impact of Karin Collett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Collett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Collett more than expected).

Fields of papers citing papers by Karin Collett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Collett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Collett. The network helps show where Karin Collett may publish in the future.

Co-authorship network of co-authors of Karin Collett

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Collett. A scholar is included among the top collaborators of Karin Collett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Collett. Karin Collett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reduced GATA3 expression associates with immuno‐metabolic alterations and aggressive features in breast cancer 2025 ·The Journal of Pathology Clinical Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Turid Aas, Ingeborg Winge, Karin Collett, Ingunn M. Stefansson, Erling A. Høivik, Lars A. Akslen, Elisabeth Wik	0
2	Placental pathology and neonatal morbidity: exploring the impact of gestational age at birth 2024 ·BMC Pregnancy and Childbirth ·(unknown), Jörg Kessler, Geir Egil Eide, Cathrine Ebbing, Karin Collett	0
3	Placental histology predicted adverse outcomes in extremely premature neonates in Norway—population‐based study 2021 ·Acta Paediatrica ·(unknown), Cathrine Ebbing, Jörg Kessler, (unknown), Olav H. Haugen, Stein Magnus Aukland, Geir Egil Eide, Thomas Halvorsen, (unknown), Karin Collett	9
4	Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups 2020 ·Scientific Reports ·(unknown), Elisabeth Wik, Kenneth Finne, Even Birkeland, Jarle B. Arnes, Karin Collett, (unknown), Kristi Krüger, (unknown), Turid Aas, Geir Egil Eide, Ingunn M. Stefansson, William D. Foulkes, Lars A. Akslen	17
5	Cholesterol Crystals and NLRP3 Mediated Inflammation in the Uterine Wall Decidua in Normal and Preeclamptic Pregnancies 2020 ·Frontiers in Immunology ·(unknown), Lobke Gierman, (unknown), (unknown), (unknown), (unknown), Bjørnar Sporsheim, Mattijs Elschot, Karin Collett, Line Bjørge, Marie Aune, Liv Cecilie Vestrheim Thomsen, Ann‐Charlotte Iversen	19
6	Placental inflammation by HMGB1 activation of TLR4 at the syncytium 2018 ·Placenta ·Line Haugstad Tangerås, (unknown), (unknown), Lobke Gierman, (unknown), Karin Collett, (unknown), Ragnhild Bergene Skråstad, Liv Cecilie Vestrheim Thomsen, Line Bjørge, Ann‐Charlotte Iversen	25
7	Fetal cerebral malakoplakia associated with recurrent facial erysipelas of the mother 2018 ·Clinical Neuropathology ·(unknown), (unknown), Paul Christoffer Lindemann, (unknown), Karin Collett, Hrvoje Miletić	0
8	Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival 2016 ·Journal of Clinical Pathology ·Tor Audun Klingen, Ying Chen, Ingunn M. Stefansson, (unknown), Karin Collett, (unknown), Hildegunn S. Aase, (unknown), Turid Aas, Elisabeth Wik, Lars A. Akslen	16
9	Evaluation of Ki67 Expression across Distinct Categories of Breast Cancer Specimens: A Population-Based Study of Matched Surgical Specimens, Core Needle Biopsies and Tissue Microarrays 2014 ·PLoS ONE ·(unknown), Ingunn M. Stefansson, (unknown), Jarle B. Arnes, Johan Eide, Karin Collett, Lars A. Akslen	52
10	Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer 2012 ·The Breast ·Kristi Krüger, Ingunn M. Stefansson, Karin Collett, Jarle B. Arnes, Turid Aas, Lars A. Akslen	51
11	Abstract 1372: Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer 2012 ·Cancer Research ·Kristi Krüger, Ingunn M. Stefansson, Karin Collett, Jarle B. Arnes, Turid Aas, Lars A. Akslen	1
12	Estrogen receptor β– an independent prognostic marker in estrogen receptor α and progesterone receptor‐positive breast cancer? 2009 ·Apmis ·Bjørn O. Mæhle, Karin Collett, Steinar Tretli, Lars A. Akslen, Tom Grotmol	20
13	Independent prognostic value of the basal‐like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI‐1 2008 ·Histopathology ·Jarle B. Arnes, Karin Collett, Lars A. Akslen	34
14	Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. 2006 ·Clinical Cancer Research ·Karin Collett, Geir Egil Eide, Jarle B. Arnes, Ingunn M. Stefansson, Johan Eide, Audun Braaten, Turid Aas, (unknown), Lars A. Akslen	226
15	A Basal Epithelial Phenotype Is More Frequent in Interval Breast Cancers Compared with Screen Detected Tumors 2005 ·Cancer Epidemiology Biomarkers & Prevention ·Karin Collett, Ingunn M. Stefansson, Johan Eide, Audun Braaten, Hege Wang, Geir Egil Eide, Steinar Thoresen, William D. Foulkes, Lars A. Akslen	170
16	EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast breakdown → 2005 ·Journal of Clinical Oncology ·Ingeborg Bachmann, Ole J. Halvorsen, Karin Collett, Ingunn M. Stefansson, Oddbjørn Straume, Svein A. Haukaas, Helga B. Salvesen, Arie P. Otte, Lars A. Akslen	694
17	The prognostic contribution of estrogen and progesterone receptor status to a modified version of the Nottingham Prognostic Index 1998 ·Breast Cancer Research and Treatment ·Karin Collett, Rolv Skjærven, Bjørn O. Mæhle	16
18	Prognostic role of oestrogen, progesterone and androgen receptor in relation to patient age in patients with breast cancer 1996 ·The Breast ·Karin Collett, Bjørn O. Mæhle, Rolv Skjærven, Turid Aas	9
19	The prognostic role of progesterone receptor status and age in relation to axillary node status in breast cancer patients 1989 ·European Journal of Cancer and Clinical Oncology ·Karin Collett, Rolv Skjærven, Thor Thorsen, F Hartveit, Bjørn O. Mæhle	4
20	Purpuric rash due to epsilon-aminocaproic acid. 1980 ·BMJ ·(unknown), Karin Collett	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact